Shenzhen Salubris Pharmaceuticals Co Ltd Capital Reinvestment Ratio

Latest as of September 2025: 0.73x

Shenzhen Salubris Pharmaceuticals Co Ltd capital reinvestment ratio. Shenzhen Salubris Pharmaceuticals Co Ltd (002294) has a Capital Reinvestment Ratio of 0.73x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥400.70 Million) in capital expenditures (CN¥292.24 Million). See 002294 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.73x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥400.70 Million
CNY

Capital Expenditures

CN¥292.24 Million
CNY

Data as of

Sep 2025
Most recent filing

Capital Reinvestment Ratio of Shenzhen Salubris Pharmaceuticals Co Ltd (2006–2024)

Capital reinvestment ratio of Shenzhen Salubris Pharmaceuticals Co Ltd from 2006 to 2024. This chart tracks Shenzhen Salubris Pharmaceuticals Co Ltd's Capital Reinvestment Ratio across 19 annual periods. See Shenzhen Salubris Pharmaceuticals Co Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Shenzhen Salubris Pharmaceuticals Co Ltd Capital Reinvestment Ratio by Year (2006–2024)

Shenzhen Salubris Pharmaceuticals Co Ltd capital reinvestment ratio by year from 2006 to 2024. For the full cash flow conversion analysis, see Shenzhen Salubris Pharmaceuticals Co Ltd (002294) cash conversion ratio.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 0.53x CN¥1.19 Billion CN¥624.81 Million ▼ -31.7%
2023 0.77x CN¥869.79 Million CN¥671.00 Million ▲ +25.0%
2022 0.62x CN¥970.80 Million CN¥598.96 Million ▲ +51.5%
2021 0.41x CN¥1.18 Billion CN¥482.50 Million ▼ -12.9%
2020 0.47x CN¥1.37 Billion CN¥642.47 Million ▲ +54.1%
2019 0.30x CN¥1.51 Billion CN¥457.19 Million ▲ +22.2%
2018 0.25x CN¥1.34 Billion CN¥332.87 Million ▲ +9.1%
2017 0.23x CN¥1.46 Billion CN¥331.67 Million ▲ +33.2%
2016 0.17x CN¥1.43 Billion CN¥245.06 Million ▼ -23.4%
2015 0.22x CN¥1.06 Billion CN¥235.57 Million ▲ +9.2%
2014 0.20x CN¥982.25 Million CN¥200.65 Million ▼ -68.0%
2013 0.64x CN¥668.52 Million CN¥427.20 Million ▲ +16.2%
2012 0.55x CN¥521.21 Million CN¥286.75 Million ▼ -40.7%
2011 0.93x CN¥272.32 Million CN¥252.60 Million ▼ -22.5%
2010 1.20x CN¥186.65 Million CN¥223.48 Million ▲ +18.5%
2009 1.01x CN¥134.28 Million CN¥135.68 Million ▲ +28.0%
2008 0.79x CN¥77.89 Million CN¥61.48 Million ▲ +203.8%
2007 0.26x CN¥52.75 Million CN¥13.71 Million ▼ -67.9%
2006 0.81x CN¥12.00 Million CN¥9.71 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow